Abbott Statement on First Family COVID-19 Diagnosis

Diagnostics Testing | Oct. 2, 2020

We wish the President and First Lady a speedy recovery. While we don’t know the details on who was tested and on which devices, we know that more than 11 million Americans have taken the ID NOW test, helping to stop the spread of the virus. We also know from our large post-authorization study that ID NOW demonstrates performance of 95% sensitivity and 98% specificity in people within 7 days post symptom onset.

Citing data from the flawed and debunked NYU study is careless and irresponsible. Science matters. The small NYU study on ID NOW was rife with limitations, including testing methods, poor sample collection, and the inclusion of many patients who were weeks after having reported symptoms.

Sign up for Abbott Edge for latest on Coronavirus